Cytogenetic consequences after occupational exposure to antineoplastic drugs (CROSBI ID 189405)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Fučić, Aleksandra ; Jazbec, Ana-Marija ; Mijić, August ; Šešo-Šimić, Đurđica ; Tomek, Rudolf
engleski
Cytogenetic consequences after occupational exposure to antineoplastic drugs
Cytogenetic monitoring was carried out on a group of 38 nurses who reconstitute antineoplastic drugs in order to determine the extent of chromosomal damage. Genotoxic activities of antineoplastic drugs are studied by chromosome aberration assay, micronucleus assay, sister chromatid exchange SCE frequency high frequency cells HFC analysis, and mitotic activity of peripheral lymphocytes. Results confirmed that occupational exposure to a mixture of antineoplastic drugs may cause genome damages. The results of this study show that biomonitoring after exposure to a mixture of antineoplastic drugs which express clastogenic and aneugenic activity should involve a battery of cytogenetic methods.
antineoplastic drug ; biomonitoring ; chromosome aberration ; SCE ; micronucleus assay ; mitotic activity ; smoking ; occupational exposure
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
416 (1/2)
1998.
59-66
objavljeno
1383-5718
1879-3592
10.1016/S1383-5718(98)00084-9
Povezanost rada
Temeljne medicinske znanosti, Kliničke medicinske znanosti